Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 14, 2014 08:30 ET | Source: Blueprint Medicines

Blueprint Medicines to Present at JMP Securities Life Sciences Private Company Conference

CAMBRIDGE, Mass., Oct. 14, 2014 (GLOBE NEWSWIRE) -- Blueprint Medicines today announced that Kyle Kuvalanka, chief business officer, will present a company overview at the JMP Securities Life Sciences...
September 30, 2014 08:30 ET | Source: Blueprint Medicines

Blueprint Medicines to Present at 13th Annual BIO Investor Forum

CAMBRIDGE, Mass., Sept. 30, 2014 (GLOBE NEWSWIRE) -- Blueprint Medicines today announced that Kyle Kuvalanka, chief business officer, will present a company overview at the 13th Annual BIO Investor...
September 09, 2014 08:30 ET | Source: Blueprint Medicines

Blueprint Medicines to Participate in Morgan Stanley Global Healthcare Conference 2014

CAMBRIDGE, Mass., Sept. 9, 2014 (GLOBE NEWSWIRE) -- Blueprint Medicines today announced that members of the Company's senior management team will participate in the Morgan Stanley Global Healthcare...
August 06, 2014 08:30 ET | Source: Blueprint Medicines

Blueprint Medicines to Present at Wedbush 2014 Life Sciences Management Access Conference

CAMBRIDGE, Mass., Aug. 6, 2014 (GLOBE NEWSWIRE) -- Blueprint Medicines today announced that members of the Company's senior management team will present at the Wedbush 2014 Life Sciences Management...
June 20, 2014 08:30 ET | Source: Blueprint Medicines

Blueprint Medicines to Present at JMP Securities Healthcare Conference

CAMBRIDGE, Mass., June 20, 2014 (GLOBE NEWSWIRE) -- Blueprint Medicines today announced that Kyle Kuvalanka, chief business officer, will present a company overview at the JMP Securities Healthcare...
April 07, 2014 08:39 ET | Source: Blueprint Medicines

Blueprint Medicines Presents Positive Data on First Selective FGFR4 Inhibitor

CAMBRIDGE, Mass., April 7, 2014 (GLOBE NEWSWIRE) -- Blueprint Medicines today announced that promising preclinical data on its first-in-class selective fibroblast growth factor receptor 4 (FGFR4)...
March 24, 2014 16:01 ET | Source: Blueprint Medicines

Blueprint Medicines to Present on the First Isoform Selective FGFR4 Inhibitor at the AACR Annual Meeting 2014

CAMBRIDGE, Mass., March 24, 2014 (GLOBE NEWSWIRE) -- Blueprint Medicines today announced that new data on its first-in-class isoform selective fibroblast growth factor receptor 4 (FGFR4) inhibitor...
March 20, 2014 16:01 ET | Source: Blueprint Medicines

Blueprint Medicines to Present at Upcoming Investor Conferences

CAMBRIDGE, Mass, March 20, 2014 (GLOBE NEWSWIRE) -- Blueprint Medicines today announced that members of the Company's senior management team will present at upcoming financial...